
Testosterone Treatment for Hypogonadism Does Not Lower Fracture Risk
Testosterone treatment in middle-aged and older men with hypogonadism was found to significantly increase the risk of clinical fractures, according to a recent analysis. The study, which involved over 5000 men, found that the testosterone group had a 43% increased risk for clinical fractures compared to the placebo group. The most common fracture sites were…